ACR-125

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameACR-125
Drug Alias Nameanti-inflammatory agent (Acretia)ACR-125
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnzymes inhibitors
TargetsEnzymes
Therapy Area/IndicationsPsoriasisKeratosisPrecancerous Conditions
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAcretia Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcretia Inc
Active IndicationsN/A
Inactive IndicationsPsoriasisKeratosisPrecancerous Conditions

Other Information

ATC CodeN/A
Related LinksN/A